Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 9;6(1):otad077.
doi: 10.1093/crocol/otad077. eCollection 2024 Jan.

Diet and Nutrition in Inflammatory Bowel Disease: A Review of the Literature

Affiliations

Diet and Nutrition in Inflammatory Bowel Disease: A Review of the Literature

Scott Manski et al. Crohns Colitis 360. .

Abstract

Diet is thought to contribute to the development of inflammatory bowel disease (IBD) and may act as a mediator of inflammation in patients with IBD. Patients commonly associate their diet with symptoms and inquire about dietary modifications to manage their IBD. Without clinical guidelines and well-established nutritional data, healthcare providers managing patients with IBD may find it difficult to provide recommendations. Strong evidence for enteral nutrition, particularly in the pediatric population, has been established in Crohn's disease (CD) as a therapeutic option. Enteral nutrition may also serve as an adjunct to an exclusion diet. Recent studies such as the randomized trial comparing the Specific Carbohydrate Diet to a Mediterranean Diet in CD patients provide additional insights in forming dietary plans. A low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in quiescent IBD and an anti-inflammatory diet have also been explored as adjunctive therapies. In this review, we discuss the latest evidence for the role of diet in IBD both as a therapeutic modality and as an opportunity to provide patient-centered care.

Keywords: IBD treatment; diet; inflammatory bowel disease; nutrition.

PubMed Disclaimer

Conflict of interest statement

R.S.: Abbvie (Clinical trial funding and speaker bureau); Janssen (IBD Fellowship funding and advisory board); BMS (speaker bureau).

Similar articles

Cited by

References

    1. Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V.. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep. 2020;10(1):19273. doi:10.1038/s41598-020-76361-2 - DOI - PMC - PubMed
    1. Collaborators GIBD. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17-30. doi:10.1016/S2468-1253(19)30333-4 - DOI - PMC - PubMed
    1. Ng SC, Shi HY, Hamidi N, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390(10114):2769-2778. doi:10.1016/S0140-6736(17)32448-0 - DOI - PubMed
    1. Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN.. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780-789. doi:10.1111/apt.14291 - DOI - PMC - PubMed
    1. Homann CM, Rossel CAJ, Dizzell S, et al. . Infants’ first solid foods: impact on gut microbiota development in two intercontinental cohorts. Nutrients. 2021;13(8):2639. doi:10.3390/nu13082639 - DOI - PMC - PubMed

LinkOut - more resources